strike a balance between the risks and benefits of using PPIs for gastroesophageal reflux disease (GERD)

May 2013

New guidelines will try to strike a balance between the risks and benefits of using PPIs for gastroesophageal reflux disease (GERD).

PPIs are still the mainstay for treating patients with GERD...even though they've been under fire for some possible drawbacks.

PPIs likely increase the risk of Clostridium difficile and other GI infections...and there are questions about a higher risk of pneumonia.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote